(TheNewswire)
Thetford Mines, Quebec – TheNewswire - February 22,2024 – KDA Group Inc. (TSXV:KDA)(“ KDA ” or the “ Corporation ”) is pleased to announce theappointments of Mr. Yves Marmet as General Manager and ChiefTechnology Officer and Ms. Marie-Hélène as Chief Operating Officerof its subsidiary Groupe Technologique KDA Inc. effectiveimmediately.
“We are very proud to welcome Yves and Marie-Hélèneto our subsidiary’s management team. Their expertise and experiencewill bring a new dynamic to the organization. We are at an importantjuncture for the growth and implementation of the Corporation’sstrategic commercialization plan. KDA is a fast-growing companyoffering a range of technology platforms and services topharmaceutical and healthcare companies. The Corporation will become akey player in healthcare and pharmaceutical technologies and servicesin Quebec, Canada and internationally. Welcome Yves andMarrie-Hélène to the KDA family,” said Marc Lemieux, ChiefExecutive Officer of KDA.
Yves Marmet –Mr. Marmet holds a Bachelor of Applied Science in ElectricalEngineering from the Université de Sherbrooke. Always looking to thefuture, he believes that the future of healthcare lies in theconvergence of megadata and artificial intelligence.
A pioneer in new technologies, Yves transformed theQuebec healthcare environment as early as 1980 with Hypocrat softwarefor pharmacists, physicians, hospitals and dental clinics. Followingunprecedented success and a series of acquisitions and mergers, hefounded ZoomMed in 2005. The company has since developed and operateda unique offering of tools and digital platforms for the exchange ofclinical interventions.
Yves brings a highly specialized expertise to KDA’smanagement team, where he will guide the deployment and marketing ofall technological projects.
Marie-Hélène Pinard – Ms. Pinard has held management positions in private andpublic companies in the medical sector, including HôpitalSte-Justine, Hôtel-Dieu de Québec and Services techniquesinformatiques STI. This career path has given her in-depth expertisein software development for the pharmaceutical, medical, radiology andlaboratory analysis markets.
Marie-Hélène co-led ZoomMed as VP Operations and CFO.For over 15 years, she acquired extensive experience in cloudsolutions for various healthcare sectors.
Recognized for her rigorous management and delivery ofworld-class projects, Ms. Pinard is leading the development of theAdherize prescription tool, as well as the optimization of the KRxPrescriber and Dental Prescriber platforms. Her calling card: thedelivery of reliable, highly efficient technologicalproducts.
DEBT SETTLEMENT
The Corporation is pleased to announce that, subject toregulatory approval, it has reached an agreementto settle indebtedness to a creditor totalling $1,236,398 in exchangefor the issuance of 4,000,000 Class A Shares of KDA (“ Common shares ”) ata price of $0.309 per Common share (the “ Debt Settlement ”).
The Debt Settlement remains subject to the approval ofthe TSX Venture Exchange. All securities to be issued under the DebtSettlement will be subject to a hold period of four months and one dayfrom the date of issuance in accordance with applicable securitiesregulations.
ABOUT KDA GROUP
KDA Group is a leader in technological innovations andspecialized solutions in the pharmaceutical market. KDA is acorporation that offers quality products and has a respected expertiseamong the various stakeholders in the pharmaceutical and medicalsectors. Its management team is guided by the vision to pursue leadingthe way in Canada and internationally. Additional information aboutthe Corporation is available at www.kdagroup.com and onSEDAR+ at www.sedarplus.ca .
- 30 -
CAUTION REGARDINGFORWARD-LOOKING STATEMENTS
This press release from KDA Groupcontains forward-looking statements. Forward-looking statements aretypically identified by the words assumption , goal , guidance , objective , outlook , strategy , target, and other similar expressions, or futureor conditional verbs such as aim , anticipate , believe , predict , could , expect , intend , may , plan , seek , should , strive, and will . By their nature, forward-looking statements require us to makeestimates and assumptions and express opinions based on currentconditions and anticipated developments, as well as other factors thatManagement may deem appropriate under the circumstances. There isinherent uncertainty and significant risk in these estimates,assumptions, and opinions, particularly of a commercial, economic, andcompetitive nature, and they are therefore subject to change. KDAGroup cannot guarantee that these estimates, assumptions, and opinionswill prove to be accurate.
Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this press release.
INFORMATION
Marc Lemieux, Chief Executive Officer
514 622-7370
Copyright (c) 2024 TheNewswire - All rights reserved.